GridAI Technologies (GRDX) Net Cash Flow (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Net Cash Flow came in at -$1.8 million in Q4 2025, down 796.23% on a YoY basis from $261720.6 in Q4 2024, and down 184.0% quarter-over-quarter from $2.2 million in Q3 2025.
Analysis
GridAI Technologies (GRDX) Net Cash Flow (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has reported Net Cash Flow for 11 consecutive years, with -$1.8 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Net Cash Flow fell 796.23% year-over-year to -$1.8 million; the trailing twelve-month figure through Dec 2025 stood at $173614.0 (up 104.89% YoY), and the FY2025 full-year result was $510041.0, up 114.37% from the prior year.
- Net Cash Flow slipped to -$1.8 million in Q4 2025 per GRDX's latest filing, from $2.2 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $6.0 million in Q1 2021 and bottomed at -$4.5 million in Q2 2022.
- Historically, Net Cash Flow has averaged -$248728.9 across 5 years, with a median of -$160975.5 in 2024.
- The sharpest annual moves came in 2023 and 2025: Net Cash Flow jumped 1451.13% in 2023, then slumped 796.23% in 2025.
- Over 5 years, Net Cash Flow stood at $962029.0 in 2021, then tumbled by 107.07% to -$68050.0 in 2022, then surged by 1451.13% to $919444.0 in 2023, then tumbled by 122.11% to -$203316.0 in 2024, then slumped by 796.23% to -$1.8 million in 2025.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$1.8 million, $2.2 million, and -$54878.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 1.95 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -4.43 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 652.90 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -504.30 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -183.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -496,000.00 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -2.09 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -170.75 Mn |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1.82 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Jun 30, 2025 | -54,878.00 |
| Mar 31, 2025 | -118,635.00 |
| Dec 31, 2024 | -203,316.00 |
| Sep 30, 2024 | -295,687.00 |
| Jun 30, 2024 | -2.77 Mn |
| Mar 31, 2024 | -279,857.00 |
| Dec 31, 2023 | 919,444.00 |
| Sep 30, 2023 | 2.06 Mn |
| Jun 30, 2023 | -828,380.00 |
| Mar 31, 2023 | 701,530.00 |
| Dec 31, 2022 | -68,050.00 |
| Sep 30, 2022 | 517,661.00 |
| Jun 30, 2022 | -4.51 Mn |
| Mar 31, 2022 | -2.54 Mn |
| Dec 31, 2021 | 962,029.00 |
| Sep 30, 2021 | -868,786.00 |
| Jun 30, 2021 | -3.91 Mn |
| Mar 31, 2021 | 5.98 Mn |